BackgroundAirway inflammation starts in early life in cystic fibrosis (CF) and limited, objective markers are available to help identify infants with increased inflammation. We aimed to investigate neutrophil, lymphocyte ratio (NLR), mean platelet volume (MPV) and immunoreactive trypsinogen (IRT) to be a possible inflammatory biomarker for CF in infancy. MethodsThis was a retrospective cohort study in three centers. Between January 2015 and December 2022, children with CF newborn screening (NBS) positivity and diagnosed as CF were included in the study. Correlation analysis were performed with NLR, MPV, IRT and follow-up parameters such as z-scores, modified Shwachman-Kulczycki score (mSKS) at the first, second, third and sixth ages and pul...
Objective: To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with ...
To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with a control g...
Background: Cystic fibrosis (CF) lung disease begins in early life and is progressive with the major...
The blood neutrophil to lymphocyte ratio (NLR) has been identified as a potentially useful marker of...
Background: In adults with cystic fibrosis (CF), induced sputum (IS) is a minimally invasive alterna...
Objective: The aim of this study is to evaluate the relationship between acute exacerbations and the...
Abstract Background There are urgent needs for clinically relevant biomarkers to identify children w...
OBJECTIVE Newborn screening (NBS) for cystic fibrosis (CF) was introduced in Switzerland in 2011 ...
Summary. Background: The relationship between lower airway markers of inflammation and infection wit...
ABSTRACT BACKGROUND: Chronic lung infections, inflammation and depletion of nutritional status are...
Controversy exists over whether the lower airway inflammation that characterizes cystic fibrosis (CF...
Cystic fibrosis (CF) is an inflammatory lung disease. Platelets have an emerging role in inflammatio...
Objectives: To determine the prevalence of bronchiectasis in young children with cystic fibrosis (CF...
The immune landscape of the paediatric respiratory system remains largely uncharacterised and as a r...
AbstractObjectiveTo compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF)...
Objective: To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with ...
To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with a control g...
Background: Cystic fibrosis (CF) lung disease begins in early life and is progressive with the major...
The blood neutrophil to lymphocyte ratio (NLR) has been identified as a potentially useful marker of...
Background: In adults with cystic fibrosis (CF), induced sputum (IS) is a minimally invasive alterna...
Objective: The aim of this study is to evaluate the relationship between acute exacerbations and the...
Abstract Background There are urgent needs for clinically relevant biomarkers to identify children w...
OBJECTIVE Newborn screening (NBS) for cystic fibrosis (CF) was introduced in Switzerland in 2011 ...
Summary. Background: The relationship between lower airway markers of inflammation and infection wit...
ABSTRACT BACKGROUND: Chronic lung infections, inflammation and depletion of nutritional status are...
Controversy exists over whether the lower airway inflammation that characterizes cystic fibrosis (CF...
Cystic fibrosis (CF) is an inflammatory lung disease. Platelets have an emerging role in inflammatio...
Objectives: To determine the prevalence of bronchiectasis in young children with cystic fibrosis (CF...
The immune landscape of the paediatric respiratory system remains largely uncharacterised and as a r...
AbstractObjectiveTo compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF)...
Objective: To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with ...
To compare the immunologic state of 44 pediatric patients with cystic fibrosis (CF) with a control g...
Background: Cystic fibrosis (CF) lung disease begins in early life and is progressive with the major...